Aptevo TherapeuticsAPVO
13F holders, Q4 2024 (December 31)13holders
$4.30avg. 13F price*
At the end of Q4 2024, 13 institutions reported holding Aptevo Therapeutics Inc. (APVO) in their 13F filings. The largest holders were Virtu Financial LLC ($93K), HRT Financial LP ($53K) and JPMorgan Chase & Co. ($20K).
- Company
- Aptevo Therapeutics Inc.
- CUSIP
- 03835L405
- Latest filing quarter
- Q2 2025
History
Number of 13F holders
Total Exit/New Position Q4 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 12 | $191K |
| Exits | 0 | $0 |
Ownership 13 holders
| Virtu Financial LLC | 0.00% | New | 21,627 | $93K |
| HRT Financial LP | 0.00% | New | 12,324 | $53K |
| JPMorgan Chase & Co. | 0.00% | New | 4,529 | $20K |
| Diadema Partners LP | 0.02% | — | 4,050 | $17K |
| Morgan Stanley | 0.00% | New | 3,927 | $17K |
| Tower Research Capital LLC (TRC) | 0.00% | New | 1,086 | $5K |
| UBS Group AG | 0.00% | New | 783 | $3K |
| SBI Securities Co., Ltd. | 0.00% | — | 131 | $565 |
| BlackRock, Inc. | 0.00% | New | 24 | $103 |
| Center for Financial Planning, Inc. | 0.00% | New | 5 | $22 |
| Bank of America Corp. | 0.00% | New | 4 | $17 |
| Danske Bank A/S | 0.00% | New | 1 | $4 |
| Osaic Holdings, Inc. | 0.00% | New | 1 | $4 |
"% of holder's portfolio" is APVO's weight in each manager's 13F, not the share of Aptevo Therapeutics Inc. the manager owns.